180 related articles for article (PubMed ID: 8632407)
1. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17.
Wächter GA; Hartmann RW; Sergejew T; Grün GL; Ledergerber D
J Med Chem; 1996 Feb; 39(4):834-41. PubMed ID: 8632407
[TBL] [Abstract][Full Text] [Related]
2. Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.
Hartmann RW; Bayer H; Grün G; Sergejew T; Bartz U; Mitrenga M
J Med Chem; 1995 Jun; 38(12):2103-11. PubMed ID: 7783141
[TBL] [Abstract][Full Text] [Related]
3. 1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase and aromatase.
Jacobs C; Frotscher M; Dannhardt G; Hartmann RW
J Med Chem; 2000 May; 43(9):1841-51. PubMed ID: 10794700
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17).
Hartmann RW; Hector M; Wachall BG; Palusczak A; Palzer M; Huch V; Veith M
J Med Chem; 2000 Nov; 43(23):4437-45. PubMed ID: 11087568
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of azole-substituted tetrahydronaphthalenes as inhibitors of P450 arom, P450 17, and P450 TxA2.
Hartmann RW; Frotscher M; Ledergerber D; Wächter GA; Grün GL; Sergejew TF
Arch Pharm (Weinheim); 1996 May; 329(5):251-61. PubMed ID: 8779634
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
Owen CP; Nicholls PJ; Smith HJ; Whomsley R
J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
[TBL] [Abstract][Full Text] [Related]
7. Imidazole substituted biphenyls: a new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer.
Wachall BG; Hector M; Zhuang Y; Hartmann RW
Bioorg Med Chem; 1999 Sep; 7(9):1913-24. PubMed ID: 10530940
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2.
Hartmann RW; Hector M; Haidar S; Ehmer PB; Reichert W; Jose J
J Med Chem; 2000 Nov; 43(22):4266-77. PubMed ID: 11063622
[TBL] [Abstract][Full Text] [Related]
9. Preparation and pharmacological profile of 7-(alpha-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors.
Marchand P; Le Borgne M; Palzer M; Le Baut G; Hartmann RW
Bioorg Med Chem Lett; 2003 May; 13(9):1553-5. PubMed ID: 12699753
[TBL] [Abstract][Full Text] [Related]
10. 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha).
Ling YZ; Li JS; Liu Y; Kato K; Klus GT; Brodie A
J Med Chem; 1997 Sep; 40(20):3297-304. PubMed ID: 9379450
[TBL] [Abstract][Full Text] [Related]
11. Effects of novel 17alpha-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo.
Haidar S; Ehmer PB; Barassin S; Batzl-Hartmann C; Hartmann RW
J Steroid Biochem Mol Biol; 2003 Apr; 84(5):555-62. PubMed ID: 12767280
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione inhibitors as potential anti-tumour agents.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Apr; 12(4):275-87. PubMed ID: 9040988
[TBL] [Abstract][Full Text] [Related]
14. 20-amino and 20,21-aziridinyl pregnene steroids: development of potent inhibitors of 17 alpha-hydroxylase/C17,20-lyase (P450 17).
Njar VC; Hector M; Hartmann RW
Bioorg Med Chem; 1996 Sep; 4(9):1447-53. PubMed ID: 8894102
[TBL] [Abstract][Full Text] [Related]
15. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase.
Recanatini M; Bisi A; Cavalli A; Belluti F; Gobbi S; Rampa A; Valenti P; Palzer M; Palusczak A; Hartmann RW
J Med Chem; 2001 Mar; 44(5):672-80. PubMed ID: 11262078
[TBL] [Abstract][Full Text] [Related]
16. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
Almadhidi J; Moslemi S; Drosdowsky MA; Séralini GE
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17.
Pinto-Bazurco Mendieta MA; Negri M; Jagusch C; Hille UE; Müller-Vieira U; Schmidt D; Hansen K; Hartmann RW
Bioorg Med Chem Lett; 2008 Jan; 18(1):267-73. PubMed ID: 18024111
[TBL] [Abstract][Full Text] [Related]
18. Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis.
Voets M; Antes I; Scherer C; Müller-Vieira U; Biemel K; Barassin C; Marchais-Oberwinkler S; Hartmann RW
J Med Chem; 2005 Oct; 48(21):6632-42. PubMed ID: 16220979
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of imidazole based compounds as cytochrome P-450 inhibitors.
Ahmed S; Smith JH; Nicholls PJ; Whomsley R; Cariuk P
Drug Des Discov; 1995 Aug; 13(1):27-41. PubMed ID: 8882899
[TBL] [Abstract][Full Text] [Related]
20. Novel imidazolyl and triazolyl substituted biphenyl compounds: synthesis and evaluation as nonsteroidal inhibitors of human 17alpha-hydroxylase-C17, 20-lyase (P450 17).
Zhuang Y; Wachall BG; Hartmann RW
Bioorg Med Chem; 2000 Jun; 8(6):1245-52. PubMed ID: 10896104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
